LYNNETTE C. FALLON - 16 May 2025 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
Director
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Lynnette C. Fallon
Issuer symbol
CLPT
Transactions as of
16 May 2025
Transactions value $
$0
Form type
4
Filing time
19 May 2025, 16:55:39 UTC
Previous filing
07 Jan 2025
Next filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FALLON LYNNETTE C Director C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH /s/ Danilo D'Alessandro, by Power of Attorney for Lynnette C. Fallon 19 May 2025 0001195654

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLPT Common Stock Options Exercise +21.1K +70.29% 51.1K 16 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLPT Restricted Stock Units Options Exercise -21.1K -100% 0 16 May 2025 Common Stock 21.1K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Remarks:

Power of Attorney is attached to this Form 4 as Exhibit 24.